170 related articles for article (PubMed ID: 38383329)
1. Distinct impacts of radiological appearance on lymph node metastasis and prognosis based on solid size in clinical T1 non-small cell lung cancer.
Li Z; Pan C; Xu W; Zhao C; Pan X; Wang Z; Wu W; Chen L
Respir Res; 2024 Feb; 25(1):96. PubMed ID: 38383329
[TBL] [Abstract][Full Text] [Related]
2. Growth characteristics of early-stage (IA) lung adenocarcinoma and its value in predicting lymph node metastasis.
Liu M; Mu J; Song F; Liu X; Jing W; Lv F
Cancer Imaging; 2023 Dec; 23(1):115. PubMed ID: 38041175
[TBL] [Abstract][Full Text] [Related]
3. Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor.
Cho JY; Leem CS; Kim Y; Kim ES; Lee SH; Lee YJ; Park JS; Cho YJ; Lee JH; Lee CT; Yoon HI
BMC Pulm Med; 2018 Sep; 18(1):151. PubMed ID: 30200917
[TBL] [Abstract][Full Text] [Related]
4. Importance of Lymph Node Evaluation in ≤2-cm Pure-Solid Non-Small Cell Lung Cancer.
Choi S; Yoon DW; Shin S; Kim HK; Choi YS; Kim J; Shim YM; Cho JH
Ann Thorac Surg; 2024 Mar; 117(3):586-593. PubMed ID: 36608755
[TBL] [Abstract][Full Text] [Related]
5. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
[No Abstract] [Full Text] [Related]
6. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of the Currently Used Nodal Stage Classification with the Number of Metastatic Lymph Nodes and the Number of Metastatic Lymph Node Stations for Non-Small Cell Lung Cancer; Which of These Is the Best Prognostic Factor?
Citak N; Aksoy Y; Isgörücü Ö; Obuz C; Acikmese B; Buyukkale S; Metin M; Sayar A
Zentralbl Chir; 2020 Dec; 145(6):565-573. PubMed ID: 31648357
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
Liu K; Chen HL; You QS; Huang JF; Wang H
Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
[TBL] [Abstract][Full Text] [Related]
9. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer.
Osaki T; Nagashima A; Yoshimatsu T; Tashima Y; Yasumoto K
Lung Cancer; 2004 Feb; 43(2):151-7. PubMed ID: 14739035
[TBL] [Abstract][Full Text] [Related]
10. [Exploration of lymph node metastasis and appropriate lymph node dissection modes in patients with clinical stage I non-small cell lung cancer].
Zhang Z; Mao Y; He J; Gao S; Cheng G; Liu X; Fang D; Li J; Wang Y; Wang D; Mu J; Xue Q; Gao Y; Zhao J; Zhang L; Huang J; Wang B; Ding N
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):536-40. PubMed ID: 25327661
[TBL] [Abstract][Full Text] [Related]
11. Extent of mediastinal nodal dissection in stage I non-small cell lung cancer with a radiological pure-solid appearance.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Eur J Surg Oncol; 2021 Jul; 47(7):1797-1804. PubMed ID: 33745792
[TBL] [Abstract][Full Text] [Related]
12. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations.
Chen W; Zhang C; Wang G; Yu Z; Liu H
Thorac Cancer; 2019 Jul; 10(7):1533-1543. PubMed ID: 31207184
[TBL] [Abstract][Full Text] [Related]
14. New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.
Zhang J; Liu L; Wang G; Huang C; Chen Y; Zhang Y; Guo C; Li S
Thorac Cancer; 2019 Dec; 10(12):2253-2258. PubMed ID: 31617316
[TBL] [Abstract][Full Text] [Related]
15. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
[TBL] [Abstract][Full Text] [Related]
16. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
17. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
18. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
[TBL] [Abstract][Full Text] [Related]
19. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of the current Japanese nodal classification on outcomes in resected non-small cell lung cancer.
Ichinose J; Murakawa T; Hino H; Konoeda C; Inoue Y; Kitano K; Nagayama K; Nitadori JI; Anraku M; Nakajima J
Chest; 2014 Sep; 146(3):644-649. PubMed ID: 24811857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
